Hepatitis D

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Hepatitis D
Classification and external resources
MeSH D003699
Hepatitis D
Virus classification
Group: Group V ((-)ssRNA)
Genus: Deltavirus
Species: Hepatitis delta virus

WikiDoc Resources for

Hepatitis D

Articles

Most recent articles on Hepatitis D

Most cited articles on Hepatitis D

Review articles on Hepatitis D

Articles on Hepatitis D in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hepatitis D

Images of Hepatitis D

Photos of Hepatitis D

Podcasts & MP3s on Hepatitis D

Videos on Hepatitis D

Evidence Based Medicine

Cochrane Collaboration on Hepatitis D

Bandolier on Hepatitis D

TRIP on Hepatitis D

Clinical Trials

Ongoing Trials on Hepatitis D at Clinical Trials.gov

Trial results on Hepatitis D

Clinical Trials on Hepatitis D at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hepatitis D

NICE Guidance on Hepatitis D

NHS PRODIGY Guidance

FDA on Hepatitis D

CDC on Hepatitis D

Books

Books on Hepatitis D

News

Hepatitis D in the news

Be alerted to news on Hepatitis D

News trends on Hepatitis D

Commentary

Blogs on Hepatitis D

Definitions

Definitions of Hepatitis D

Patient Resources / Community

Patient resources on Hepatitis D

Discussion groups on Hepatitis D

Patient Handouts on Hepatitis D

Directions to Hospitals Treating Hepatitis D

Risk calculators and risk factors for Hepatitis D

Healthcare Provider Resources

Symptoms of Hepatitis D

Causes & Risk Factors for Hepatitis D

Diagnostic studies for Hepatitis D

Treatment of Hepatitis D

Continuing Medical Education (CME)

CME Programs on Hepatitis D

International

Hepatitis D en Espanol

Hepatitis D en Francais

Businness

Hepatitis D in the Marketplace

Patents on Hepatitis D

Experimental / Informatics

List of terms related to Hepatitis D

Hepatitis D is a disease caused by a small circular RNA virus (Hepatitis delta virus or hepatitis D virus, HDV). HDV is considered to be a subviral satellite because it can propagate only in the presence of another virus, the hepatitis B virus (HBV). Transmission of HDV can occur either via simultaneous infection with HBV (coinfection) or via infection of an individual previously infected with HBV (superinfection). Both superinfection and coinfection with HDV results in more severe complications compared to infection with HBV alone. These complications include a greater likelihood of experiencing liver failure in acute infections and a greater likelihood of developing liver cancer in chronic infections. In combination with hepatitis B virus, hepatitis D has the highest mortality rate of all the hepatitis infections of 20%.

Genome structure and similarities to viroids

The HDV genome exists as a negative sense, single-stranded, closed circular RNA. Because of a nucleotide sequence that is 70% self-complementary, the HDV genome forms a partially double stranded RNA structure that is described as rod-like. With a genome of approximately 1700 nucleotides, HDV is the smallest "virus" known to infect animals. However, it has been proposed that HDV may have originated from a class of plant viruses called viroids. Evidence in support of this hypothesis stems from the fact that both HDV and viroids exist as single-stranded, closed circular RNAs that have rod-like structures. Likewise, both HDV and viroids contain RNA sequences that can assume catalytically active structures called ribozymes. During viral replication, these catalytic RNAs are required in order to produce unit length copies of the genome from longer RNA concatamers. Finally, neither HDV nor viroids encode their own polymerase. Instead, replication of HDV and viroids requires a host polymerase that can utilize RNA as a template. Based on indirect evidence, RNA polymerase II has been implicated in the replication of HDV. Normally RNA polymerase II utilizes DNA as a template and produces mRNA. Consequently, if HDV indeed utilizes RNA polymerase II during replication, it would be the only known pathogen capable of converting a DNA dependent polymerase into an RNA dependent polymerase.

Cirrhosis of the liver and liver cancer may ensue from Hepatitis D.
Cirrhosis of the liver and liver cancer may ensue from Hepatitis D.

The Delta Antigens

A significant difference between viroids and HDV is that, while viroids produce no proteins, HDV produces two proteins called the small and large delta antigens (HDAg-S and HDAg-L, respectively). These two proteins are produced from a single open reading frame. They are identical for 195 amino acids and differ only by the presence of an additional 19 amino acids at the C-terminus of HDAg-L. Despite having 90% identical sequences, these two proteins play diverging roles during the course of an infection. HDAg-S is produced in the early stages of an infection and is required for viral replication. HDAg-L, in contrast, is produced during the later stages of an infection, acts as an inhibitor of viral replication, and is required for assembly of viral particles.

External links


Viruses templates

de:Hepatitis Dit:Epatite virale D

ja:D型肝炎


WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools
In other languages